MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, RNTX has $26,288K in assets. $14,697K in debts. $4,445K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
39.99%
Quick Ratio
39.99%
Cash Ratio
32.60%
Debt to Asset Ratio
55.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible assets
    • Goodwill
    • Cash and cash equivalents
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Convertible preferred stock, 0.0...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
4,445 3,215 4,048 5,722
Prepaid expenses and other current assets
1,008 1,111 1,126 880
Total current assets
5,453 4,326 5,174 6,602
Property and equipment, net
-0 0 1
Goodwill
6,330 6,330 6,330 6,330
Intangible assets
13,500 13,500 42,200 42,200
Other non-current assets
1,005 2 2 2,346
Total assets
26,288 24,158 53,706 57,479
Accounts payable
6,263 3,976 4,123 6,028
Accrued expenses and other current liabilities
2,451 2,204 1,621 1,666
Notes payable, net
4,923 ---
Total current liabilities
13,637 6,180 5,744 7,694
Other long-term liability
-0 0 0
Deferred tax liability
1,060 1,060 1,772 1,772
Total liabilities
14,697 7,240 7,516 9,466
Convertible preferred stock, 0.001 par value, 5,000,000 shares authorized at march 31, 2026 and at december 31, 2025 24,610 shares issued and 12,232 shares outstanding at march 31, 2026 and at december 31, 2025
45,005 45,005 45,005 45,005
Common stock, 0.001 par value 100,000,000 shares authorized at march 31, 2026 and at december 31, 2025 28,039,032 shares and 27,550,222 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
114 113 111 109
Common stock subscribed
---22
Additional paid-in capital
373,643 373,133 370,422 366,644
Accumulated other comprehensive loss
-62 -62 -44 -44
Accumulated deficit
-407,109 -401,271 -369,304 -363,723
Total liabilities, convertible preferred stock and stockholders' equity
26,288 24,158 53,706 57,479
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$4,445K Prepaid expenses andother current assets$1,008K Intangible assets$13,500K Goodwill$6,330K Total current assets$5,453K Other non-currentassets$1,005K Total assets$26,288K Total liabilities,convertible preferred stock...$26,288K Accumulated deficit-$407,109K Accumulated othercomprehensive loss-$62K Additional paid-in capital$373,643K Convertible preferredstock, 0.001 par value,...$45,005K Total liabilities$14,697K Common stock, 0.001 parvalue 100,000,000...$114K Total currentliabilities$13,637K Deferred tax liability$1,060K Accounts payable$6,263K Notes payable, net$4,923K Accrued expenses andother current...$2,451K

Rein Therapeutics, Inc. (RNTX)

Rein Therapeutics, Inc. (RNTX)